CLDN1 and digestive system neoplasm: These results indicate that sodium butyrate significantly increases the expression of intestinal Occludin, Claudin-1, and ZO-1 proteins, improves intestinal permeability, and reduces serum LPS levels, thus reducing liver inflammation and improving alcohol-induced hepatic function impairment.